Cite
Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy
MLA
Masanori Someya, et al. “Predictive Value of an Exosomal MicroRNA-Based Signature for Tumor Immunity in Cervical Cancer Patients Treated with Chemoradiotherapy.” Medical Molecular Morphology, vol. 56, Nov. 2022, pp. 38–45. EBSCOhost, https://doi.org/10.1007/s00795-022-00338-5.
APA
Masanori Someya, Tomokazu Hasegawa, Takaaki Tsuchiya, Mio Kitagawa, Yuki Fukushima, Toshio Gocho, Shoh Mafune, Yutaro Ikeuchi, Yoh Kozuka, Masashi Idogawa, Yoshihiko Hirohashi, Toshihiko Torigoe, Masahiro Iwasaki, Motoki Matsuura, Tsuyoshi Saito, & Koh-ichi Sakata. (2022). Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy. Medical Molecular Morphology, 56, 38–45. https://doi.org/10.1007/s00795-022-00338-5
Chicago
Masanori Someya, Tomokazu Hasegawa, Takaaki Tsuchiya, Mio Kitagawa, Yuki Fukushima, Toshio Gocho, Shoh Mafune, et al. 2022. “Predictive Value of an Exosomal MicroRNA-Based Signature for Tumor Immunity in Cervical Cancer Patients Treated with Chemoradiotherapy.” Medical Molecular Morphology 56 (November): 38–45. doi:10.1007/s00795-022-00338-5.